CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Consort Medical Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Consort Medical Ltd
Breakspear Park, Breakspear Way
Phone: +44 1442867920p:+44 1442867920 Hemel Hempstead, HP2 4TZ  United Kingdom Fax: +44 1442245237f:+44 1442245237

This is a Subsidiary, click here for the Parent Company

Business Summary
Consort Medical PLC is a United kingdom-based company that operates as a holding company. The Company wit its subsidiaries engaged in contract development and manufacturing organization (CDMO). The Company's services include designing, development and manufacture of medical drug delivery devices and services for the pharmaceutical industry. The Company operates through two segments: Bespak and Aesica. Bespak's core business is the manufacture of inhaled drug delivery devices for life sciences partners and its operations are based in the United Kingdom. The Aesica business manufactures and sells active pharmaceutical ingredients (API), formulated pharmaceutical products and packaging services to the pharmaceutical industry and its operations are based in the United Kingdom and Europe. It offers its services to customers, such as pharmaceutical companies and life sciences.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-Yes---

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
1/31/20201/31/2020Yes---Yes

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chief Financial Officer Daniela Sylvia BeateRoxin 54 5/1/2021 5/1/2021
Director Jean-FrancoisHilaire 58 3/15/2021 3/15/2021
Director OrenKlug 38 3/15/2022 3/15/2022
Director LisaLodge 36 5/6/2022 5/6/2022

Business Names
Business Name
Aesica BC Limited
Aesica Formulation Development Limited
Aesica Holdco Ltd
21 additional Business Names available in full report.

General Information
Number of Employees: 1,978 (As of 1/31/2020)
Outstanding Shares: 49,731,097 (As of 2/4/2020)
Shareholders: 3,122
Stock Exchange: LON
Fax Number: +44 1442245237


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, September 12, 2023